Our Research

Cancer Immunotherapy

Our Investigators

Lawrence Fong, MD Leader, Cancer Immunotherapy Program Efim Guzik Distinguished Professor in Cancer Biology, UCSF Genitourinary cancer specialist, UCSF Medical Center

Bridget Keenan, MD, PhD Medical Director, Cancer Immunotherapy Clinic Assistant Professor, Division of Hematology/Oncology Medical Oncologist, UCSF Medical Center

David Y. Oh, MD, PhD Assistant Professor In Residence, Division of Hematology/Oncology Medical Oncologist, Cancer Immunotherapy Program, UCSF

Peter Sayre, MD, PhD Site Co-Leader, Cancer Immunotherapy Program Blood disorder specialist, UCSF Medical Center

Katy Tsai, MD Assistant Professor, Department of Medicine, Division of Hematology/Oncology, UCSF Melanoma specialist, UCSF Medical Center

Cancer Immunotherapy Program

Faculty of the Cancer Immunotherapy Program (left to right): Bridget Keenan, MD, PhD, David Oh, MD, PhD, Lawrence Fong, MD, and Peter Sayre MD, PhD.

Dr. Bridget Keenan discusses tumor immunology and immunotherapy for colorectal cancer.



Dr. Lawrence Fong: Immuntherapy and Prostate Cancer

About Cancer Immunotherapy

While much has been accomplished in recent years to better understand the role of the immune system in fighting cancer, there remains much more work to be done. Both laboratory and clinical research have allowed us to gain a more in-depth understanding of the way that cancer cells evade the immune system, thereby allowing us to develop new drugs to target these pathways. Historically, cancer researchers and clinicians have focused on studying a specific type of cancer. It is now clear, however, that by better understanding the immune system as a whole, it may be possible to find treatments that are not specific to just one type of cancer, but that could potentially treat all cancers.